FDA Recalls Risk Communication Advisory Committee David K. Elder Director, Office of Enforcement.

Slides:



Advertisements
Similar presentations
Introduction of the new Canada Consumer Product Safety Act Technical Briefing January 29, 2009.
Advertisements

Major Accident Prevention Policy (MAPP) and Safety Management System (SMS) in the Context of the Seveso II Directive.
The Boston Seafood Show March 16, 2009 Presentation by: CDR Domenic J. Veneziano, Director, Division of Import Operations DIOP Division of Import Operations.
ALERT: The Basics Food and Drug Administration Center for Food Safety and Applied Nutrition.
Development of Guidance Documents Jennifer Scharpf, M. P. H
How OSHA Conducts Inspections
1 OSHA FEDERAL OCCUPATIONAL SAFETY AND HEALTH ACT (OSHA) OF 1970 George Mason University College of Nursing and Health Science Regulatory Requirements.
© 2005 by Nelson, a division of Thomson Canada Limited. 1 Consumer Stakeholders: Product and Service Issues Search the Web The American Society for Quality.
Susan Best, NRL, Australia WHO post-market surveillance for In Vitro Diagnostic Devices (IVD)
1 Human Factors/Usability for Medical Devices: An Historical Perspective Ron Kaye Human Factors Premarket Review, Team Leader Office of Device Evaluation,
© 2005 Notification and Reporting on Food Incidents: Irish Approach Food & Drugs Authority Bangkok Thailand Dorothy Guina-Dornan.
Introduction to Regulation
John Naim, PhD Director Clinical Trials Research Unit
Business and Society: Ethics and Stakeholder Management, 5E Carroll & Buchholtz Copyright ©2003 by South-Western, a division of Thomson Learning. All.
Regulatory Body MODIFIED Day 8 – Lecture 3.
Opportunities for RAC Participation. Three Part discussion General presentation; Example of oil and gas decision making; and Panel Discussion of RAC involvement.
Supplier Ethics: Program Checklist
Field Investigators: ADE Detectives. Section One Introduction to the Team and Their Roles.
External Defibrillators: Recalls, Inspections, and the Quality System Regulation Melissa Torres Office of Compliance December 15, 2010.
Business and Society: Ethics and Stakeholder Management, 5E Carroll & Buchholtz Copyright ©2003 by South-Western, a division of Thomson Learning. All.
Assessing the Impact of a Toll-Free Number for Reporting Side Effects in Direct-to-Consumer Television Ads: Proposed Study Design Kathryn J. Aikin, Ph.D.
Arnold Best Recall Coordinator U. S. Food & Drug Administration.
Proposed Rules to Help Ensure the Safety of Imported Food 1.
FDA Resources and Meetings FDA/EMA Orphan Designation and Grant Workshop Silver Spring, Maryland FDA Campus (White Oak) October 12, 2012 Bill Sutton Deputy.
Are you ready for a recall? Medical Device Regulatory, Reimbursement and Compliance Congress March 28, 2007 Willie R. Bryant, Jr. Consultant Stericycle,
OH&S Management System
Introduction to US Health Care
Center for Veterinary Medicine (CVM) RECALLS.  21 CFR 7.40 provides guidance on the policy, procedures, and industry responsibilities for recalls. 
Food & Drug Law Institute Conference on Products Liability For FDA Regulated Products January 26, 2005 Recalls: The First Smoke of A Mass Tort Overview.
A royal decree was issued on Feb.13, 2007 assigned the responsibility for regulating medical devices, in vitro diagnostic devices, prescription eye glasses,
FDA Regulatory review in Minutes: What Product Development Executives Need-to-Know. Specifically, frequent causes of recalls and related areas that investigators.
What is Food Recall A food recall is a voluntary action by a manufacturer or distributor to protect the public from products that may cause health problems.
A CASE OF RECALL POLICY AND ITS APPLICATIONS OCCURRED IN A COMPANY THAT PRODUCES AND PACKAGES PASTEURIZED MILK Alejandra Colina Ibarra University of Guelph.
WHO COURSE FOR THE CARs MONITORING AND AUDITING OF FOOD LAW COMPLIANCE AND ENFORCEMENT.
Top 10 Medical Device Citations
Elizabeth McNulty Head of Incident Response Food Standards Agency.
Chapter 6 CRISIS MANAGEMENT. Introduction - Crisis: ◦is a situation that specifically involves a pharmaceutical product, medical device or activity with.
Proposed Regulations for Foreign Supplier Verification Programs (FSVPs)
1 Investigating Fraud & Abuse Violations in Medical Research Janet Rehnquist, Esq. Venable LLP th Street, NW Washington, DC
Latham & Watkins operates as a limited liability partnership worldwide with affiliated limited liability partnerships conducting the practice in the United.
COMPLIANCE ACTIONS FDA Regulation & Licensure of Whole Blood & Blood Components, Including Source Plasma September 15-16, 2009 Helen Cowley Office of Compliance.
Avoid Disputes, Not Complaints Presented by: Stuart Ayres and Derek Pullen Stuart Ayres, Scheme Manager Derek Pullen, Scheme Adjudicator.
UMBC POLICY ON ESH MANAGEMENT & ENFORCEMENT UMBC Policy #VI
Organization and Implementation of a National Regulatory Program for the Control of Radiation Sources Regulatory Authority.
Rules for Supporting Part 803 and Part 806 Decision Making Page 1 Establishing Rules for: Medical Device Reports (803) & Correction and Removal Reports.
Dispensary and Administration Site Information Presentation.
FDAAA – Report on DTC Advertising Kristin Davis, J.D. Deputy Director, Division of Drug Marketing, Advertising, and Communications Office of Medical Policy,
FDA Regulatory and Compliance Symposium
Competency-Development Project 08-October MDIC 2 What is the Competency-Development Project? ‏ Purpose: The purpose of this project is to improve.
FDA job description  Regulates about 25% of all consumer purchases  Mission summary: protect and advance public health  Products: food, cosmetics, drugs,
FDA Risk Communication Nancy M. Ostrove, PhD Senior Advisor for Risk Communication Risk Communication Advisory Committee February 28, 2008.
Complaint and recall 1. Title 21--food and drugs Chapter I- food and drug administration department of health and human services Subchapter A- General.
Office of Food Safety and Recall Food Safety Investigation and Recall Presented by: Francis Lindsay, CFIA Technical Specialist Querétaro, México, October.
Organization and Implementation of a National Regulatory Program for the Control of Radiation Sources Program Performance Criteria.
27 June 2000Victor F. C. Raczkowski, M.D.1 Risk-Management Options Victor F. C. Raczkowski, M.D., M.S. Gastrointestinal Drugs Advisory Committee 27 June.
Complaint Handling Medical Device Reporting May 19, 2016 Rita Harden, Director Customer Relations & Regulatory Reporting.
© 2009 Michigan State University licensed under CC-BY-SA, original at Incident Management.
KEVIN BEDAL LISA CARLIN MATT CARROLL ERIN NICHOLS Product Safety & Failure Analysis.
FSMA TRAINING Industry Recall Readiness BEST PRACTICES.
OH&S Management System
NRC’s 10 CFR Part 37 Program Review of Radioactive Source Security

By Rebecca Moulder GRIT 700
Recalls Neisa M. Alonso Emergency Response Coordinator US FDA / SJN-DO
American Society for Quality Region 5 Quality Conference
OH&S Management System
Overview of FDA Food Inspections
FDA Resources and Meetings
Linda M. Chatwin, Esq. RAC Business Manager, UL LLC
Final Rule on Foreign Supplier Verification Programs
Presentation transcript:

FDA Recalls Risk Communication Advisory Committee David K. Elder Director, Office of Enforcement

FDA Overview  Regulates about 25% of all consumer purchases  Mission summary: protect and advance public health  Products: food, cosmetics, drugs, biologics, medical devices  Pre-market and post-market responsibilities and operations  About 10,000 employees operating in product Centers, OC, and ORA

FDA Organizational Structure

What is a Recall? Recall – a firm’s removal or correction of a marketed product that is in violation of the law, and against which FDA would initiate legal action. Reference: 21 CFR 7.3(g)

FDA inspection How Does FDA Learn About a Problem with a Regulated Product? Firm Testing FDA Sample Collection & Analysis Other Health Agencies CDC Epidemiological Information Adverse Event Reports 3 rd party information NDA Field Reports

What Does a Firm Do When a Problem is Detected in a Marketed Product?  Review, analyze, discuss, debate  Often get to the decision point: ‘remove the product from the market’  Then: scope, strategy, notification, execution, verification, and analysis

Steps Taken By a Firm When Conducting a Recall  Scope – the specific products to recall  Strategy – the plan to execute the removal or correction to minimize risk of illness/injury from recalled product  Notification – inform FDA* of the planned recall; offering the opportunity to comment on the scope and strategy.

Steps Taken By a Firm When Conducting a Recall (cont’d)  Execution - make the recall happen; calls, s, faxes, letters, visits, internet posting, press releases  Verification - ensure execution of the strategy was performed effectively  Analysis - review overall effort and identify opportunities for improvement

Steps Taken By FDA in the Recall Process  Assess situation & obtain recall related information (e.g. labeling, distribution, testing)  Investigate - What went wrong? What steps were taken to prevent recurrence?  Evaluate scope and strategy - Is it appropriate in light of the risk? Adjustments needed? Other steps needed? Additional public notice necessary?

Steps Taken By FDA in the Recall Process (cont’d)  Health hazard evaluation and classification of the recall; publication in the Enforcement Report  Recall audit checks; level is set based on risk to verify the effectiveness of the recall efforts

How is a Recall Classified?  Class 1 - highest risk; reasonable probability of serious adverse health consequences or death  Class 2 - medium risk; may cause temporary or medically reversible adverse health consequences and probability of serious adverse health consequences is remote  Class 3 – low risk; adverse health consequences are unlikely Classification is a legal determination based on the health hazard evaluation. FDA oversight is commensurate with risk and therefore proportional to classification Reference: 21 CFR 7.3(m)

When is a Recall Classified?  Upon receipt and review of all pertinent information relevant to the recall  After an assessment of the health hazard associated with the recalled product has been made  As soon as reasonably possible

What Are the Practical Implications of a Recall Classification? Class 1 & 2 Recalls May Require Additional Actions Be Undertaken: –Option for FDA to issue a public warning per 21 CFR 7.42(b)(2) –Guidance to Industry recommends procedures for issuing Public Notifications (Press Releases) in certain situations

Public Communication Class 1 Recall: –Prompt, clear, accurate communication reduces the risk of serious injury or death –Press Releases are usually issued to enhance the consumer’s awareness of the recall and the steps that should be taken

Public Communication (cont’d) Class 1 Recall: –Press releases also post to the FDA internet site and are sent to all state health agencies, foreign governments, and various other stakeholders –There are several hundred Class 1 recalls per year across all FDA regulated products – Look how The Washington Post now presents product recall notices…

Daily Washington Post Notices

Legislation and New Initiatives  FDAAA Section 1003 –Enhance the quality and speed of communication with the public –Post information that is easily accessed and understood by the public  Food Protection Plan –Improve the food protection communication process to increase timeliness of food protection messages –Better inform consumers and other stakeholders during food related emergencies

Legislation and New Initiatives (cont’d)  Import Safety Action Plan –Provide FDA with mandatory food recall authority –Develop best practices for the use of technologies to expedite consumer notification of recalls

Oversight and Evaluations Congressional, HHS Office of the Inspector General, Government Accountability Office Concerns: –Timely, clear, effective communication –Interagency cooperation and collaboration –Prompt and complete execution of recalls (ensuring all recalled product is removed from distribution channels)

How Can RCAC Help? In light of legislation, initiatives, oversight, evaluations and FDA intent to seek process improvements: –Provide feedback on draft Press Release template –Assist us in applying risk communication principles to improve the timeliness, clarity, accuracy, consistency, and ultimately, the effectiveness, of this method of public communication

Help by Answering Key Questions  Standardization of the draft template in FDA  Substance and format (blocking, information mapping) of the draft template  Incorporating other Recommended Communication Practices into the template  Other advice for Recommended Communication Practices beyond the use of the Press Release template